Patents Assigned to Oncologic, Inc.
  • Patent number: 7615221
    Abstract: The invention features compositions and methods for treating or alleviating a symptom of cancer. The compositions and methods of the invention direct supra-lethal doses of radiation, called Hot-Spots, to virtually all cancer cell types.
    Type: Grant
    Filed: July 23, 2004
    Date of Patent: November 10, 2009
    Assignee: Oncologic, Inc.
    Inventors: George L. Mayers, David Lee, Hsiao-Ling Chin
  • Patent number: 6468503
    Abstract: A method for the treatment of cancer is disclosed which is capable of directing supra-lethal doses of radiation, called Hot-Spots, virtually exclusively to the cancer. The present invention involves a multi-step therapy process and includes a class of novel chemical agents. In accordance with the present invention, it was discovered that soluble precipitable materials can be made to accumulate as non-digestible precipitates in targeted cells as a result of enzyme action within the targeted cells. Accumulation is achieved by administering to the living host a soluble binary reagent made by attaching a targeting agent to a novel chemical agent which is a soluble precipitable material. The binary reagent binds to antigenic receptors on targeted cells which endocytose the binary reagent and transport it into the lysosomes where enzymes detach the soluble precipitable material from the targeting agent, causing it to precipitate, accumulate, and be retained in the cells.
    Type: Grant
    Filed: May 18, 1999
    Date of Patent: October 22, 2002
    Assignee: Oncologic, Inc.
    Inventor: Samuel Rose